Nea Management Company, LLC Akari Therapeutics PLC Transaction History

Nea Management Company, LLC

  • $1.31 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2017

Nov 03, 2017
BUY
$3.42 - $8.74 $1.55 Million - $3.95 Million
452,167
452,167 $2.78 Million

About Akari Therapeutics Plc

AKTX Quotes by TradingView
  • Ticker AKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,349,200
  • Market Cap $59.3M
  • Description
  • Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...
More about AKTX
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email